DISCOVERY
We get clear on the product, people, market and intended outcome.
01 — ALIGNHEALTH COMPLIANCE / REGULATORY STRATEGY
SIGNATURECOMPLIANCE
[EST. FOR MARKET-READY HEALTH PRODUCTS]
SCROLL TO EXPLORE ↓
[01]ABOUT / POSITIONING
WE TURN COMPLEX REGULATION INTO A CLEAR PATH FROM IDEA TO MARKET.
Signature Compliance Co. is a small expert team of health compliance specialists, formulation scientists and regulatory strategists built for founders and brands who refuse to let complexity block the vision.
We validate the science, pressure-test the claims and embed compliance from day one — before the formula, label or market-entry decision becomes expensive to change.
OUR MARKETS
TGA
FSANZ
FDA
GLOBAL
[02]EXPERTISE
TGA / FSANZ / CLAIMS / LABELSAUS REGULATORY AFFAIRS
FDA / INGREDIENT / SUBSTANTIATIONUSA REGULATORY AFFAIRS
PATHWAY / COMMERCIAL OPPORTUNITYGLOBAL MARKET ANALYSIS
RESEARCH / HEALTH DATA / ROADMAPCLINICAL STRATEGY
FORMULA / PROTOTYPE / SIGN-OFFPRODUCT DEVELOPMENT
GMP / FORMAT / VOLUME MATCHMANUFACTURER CONNECTIONS
COMPLIANCE ISN'T A BARRIER.
IT'S YOUR ADVANTAGE.
IT'S YOUR ADVANTAGE.
[03]BUILT FOR HEALTH INNOVATION
01 / 05
From capsule to claims language — every detail mapped to the market.
[04]SIGNATURE LABS
BUILT ONSCIENCE.READY FORTHE SHELF.
01EVIDENCE REVIEW
02INGREDIENT VALIDATION
03FORMULATION + PROTOTYPE
04COMPLIANCE SIGN-OFF
[05]HOW WE WORK
PRECISION
BEFORE
EXECUTION.
One conversation, done properly. Then a structured path that catches risk early and keeps the build commercially useful.
VALIDATION
Your concept is pressure-tested across science, ingredients, claims and regulatory fit.
02 — TESTSTRATEGIC SCOPE
We define the pathway, decisions, evidence and work required before execution.
03 — DEFINEBUILD
Formula, documentation, labels and partner coordination move forward with compliance embedded.
04 — EXECUTE[06]REGULATORY SYSTEM
MARKET
READINESS
WITHOUT
GUESSWORK.
READINESS
WITHOUT
GUESSWORK.
AUSTRALIATGA / FSANZClaims • labels • ingredients • audit readiness
UNITED STATESFDAClaims • labels • substantiation • market entry
EUROPE + GLOBALEFSA / PATHWAYRegulatory pathway • opportunity • risk mapping
[07]REGULATORY INTELLIGENCE
TURN KNOWLEDGE
INTO LEADS.
A preview of how Signature's future WordPress site can turn expertise into gated resources and digital products without looking like a template store.
01TGA
READINESS
CHECKLISTSIGNATURE / INTELLIGENCE
READINESS
CHECKLISTSIGNATURE / INTELLIGENCE
TGA Compliance Readiness
Concept resource — gated PDF.
02FDA
LABEL REVIEW
SCORECARDSIGNATURE / INTELLIGENCE
LABEL REVIEW
SCORECARDSIGNATURE / INTELLIGENCE
FDA Label Review Scorecard
Concept resource — gated scorecard.
03GLOBALMARKET ENTRY
GUIDESIGNATURE / INTELLIGENCE
Global Market Entry Guide
Concept resource — downloadable guide.
GET THE NEXT REGULATORY NOTEONE USEFUL EMAIL.
NO NOISE.
NO NOISE.
[08]A NOTE FROM THE FOUNDER
SCIENCE FIRST / PEOPLE ALWAYS
“WE START WITH PEOPLE. THE HEALTH CHALLENGES THEY FACE, THE OUTCOMES THEY NEED, THE SCIENCE THAT CAN GET THEM THERE.”— AMELIA, FOUNDER & DIRECTOR
From day one, compliance and governance sit at the centre of everything we build. Before a formula is written, before a market is entered, before a claim is made.
Every formulation grounded in evidence. Every product signed off to the standards that protect the people it was built for.
[09]CLIENT REVIEWS
01/03
“Honestly, TGA and FSANZ used to do my head in. Amelia's team went through everything, told us what actually needed fixing and in what order. First time I've felt like we're on solid ground.”
— JUSTIN“We engaged Signature before we'd even finalised our formulation, and it turned out to be the best decision we made. They pressure-tested our ingredients and claims against the regulations from day one.”
— ELLA“Signature translated our Australian compliance position into a US-ready one — claims, labels and substantiation mapped for both markets. Having one partner across both jurisdictions easily saved us months.”
— KATIE & JOSHBUILD ITRIGHTFROM DAY ONE.
Tell us what you're building.
We'll help you find the compliant path to market.